KANSAS CITY, Mo.--(BUSINESS WIRE)--Diatron Group (Diatron), a Swiss-based company and global provider of hematology and clinical chemistry analyzers, has received FDA 510(k) premarket approval for its advanced laser optics hematology analyzer. The approval allows Diatron to begin commercial operations for the device in the U.S.
